Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists

<table>Scatterplot showing patient’s change in FEF<sub>25–75%</sub> (% predicted) comparing those that maintained asthma control off LABA therapy at followup (controlled) and those that experienced loss of asthma control (uncontrolled).</table>

Pulmonary Medicine

fig2

Figure 2

Figure 2: Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists 